In cancer, interleukins (ILs) induce neo-angiogenesis and enhance the activity of MMPs, which increases the metastatic activity as demonstrated in hepatocellular carcinoma where IL-8 and IL-17 cause MMP-2 and MMP-9 activation (40). Here, CXCL8 is linked to hepatocellular carcinoma.